These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9427782)

  • 21. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement therapy after endometrial or ovarian cancer].
    Daraï E; Gompel A; Deval B; Laplace C; Lemoine A; Labeyrie E; Neu AM; Poitout P
    Gynecol Obstet Fertil; 2000 Mar; 28(3):198-204. PubMed ID: 10786400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and combined hormone therapy for women after genital malignancies: a review.
    Levgur M
    J Reprod Med; 2004 Oct; 49(10):837-48. PubMed ID: 15568410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and ovarian cancer risk--any news?
    Riman T
    Acta Obstet Gynecol Scand; 2007; 86(9):1032-4. PubMed ID: 17712640
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-progestogen replacement therapy and ovarian cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Dec; 15(6):490-2. PubMed ID: 17106327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal hormone-replacement therapy.
    Hilmy N
    N Engl J Med; 2002 Jan; 346(1):63-5. PubMed ID: 11799954
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Neves-E-Castro M
    Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern tendencies in HRT of patients treated for endometrial cancer].
    Ivanov C
    Akush Ginekol (Sofiia); 2009; 48(2):20-2. PubMed ID: 20198772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormonal replacement therapy in patients with cervical and ovarian cancers].
    Urdl W
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):89-92. PubMed ID: 9815524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal estrogens and progestogens and the incidence of gynecologic cancer.
    Weiss NS; Hill DA
    Maturitas; 1996 Mar; 23(2):235-9. PubMed ID: 8735361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.
    Fournier A; Dossus L; Mesrine S; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
    Am J Epidemiol; 2014 Sep; 180(5):508-17. PubMed ID: 25008104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status: hormone substitution and risk of endometrial carcinoma].
    Kuhl H
    Zentralbl Gynakol; 1997; 119(6):296-7. PubMed ID: 9312968
    [No Abstract]   [Full Text] [Related]  

  • 36. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial cancer. Prevention, detection, management, and follow up.
    Elit L
    Can Fam Physician; 2000 Apr; 46():887-92. PubMed ID: 10790821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.